✦ LIBER ✦

A Phase I dose-escalation study of the VEGFR inhibitor tivozanib hydrochloride with weekly paclitaxel in metastatic breast cancer

✍ Scribed by Mayer, Erica L.; Scheulen, M. E.; Beckman, J.; Richly, H.; Duarte, A.; Cotreau, M. M.; Strahs, A. L.; Agarwal, S.; Steelman, L.; Winer, E. P.; Dickler, M. N.

Book ID: 121631327
Publisher: Springer US
Year: 2013
Tongue: English
Weight: 280 KB
Volume: 140
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-013-2632-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I intrapatient dose escalation stu

Phase I intrapatient dose escalation study of weekly epirubicin and docetaxel as first line chemotherapy in metastatic breast cancer

✍ N Lo; S Ayers; E Catell; B Koetz; N Singh; G Alexander; F Lowe; D.W Rea 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 163 KB

Low dose capecitabine plus weekly paclit

Low dose capecitabine plus weekly paclitaxel in patients with metastatic breast cancer: a multicenter phase II study KBCSG-0609

✍ Tetsuya Taguchi, Daigo Yamamoto, Norikazu Masuda… 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 231 KB

Phase I dose finding study evaluating th

Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial

✍ Sibylle Loibl; Caroline Murmann; Katrin Schwedler; Mathias Warm; Lothar Müller; 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 326 KB

A phase I study of weekly one hour escal

A phase I study of weekly one hour escalating dose of paclitaxel infusion in conjunction with amifostine in patients with advanced cancer

✍ Akhtar, S.; Bradshaw, D.; Wright, J. 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 135 KB

360 Phase I/II study with paclitaxel in

360 Phase I/II study with paclitaxel in combination with weekly high dose 5-FU/Folinic acid in the treatment of metastatic breast cancer

✍ U. Klaassen; H. Wilke; D. Strumberg; C. Philippou Pari; A. Harstrick; W. Eberhar 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Phase I study of a weekly schedule of a

Phase I study of a weekly schedule of a fixed dose of cisplatin and escalating doses of paclitaxel in patients with advanced oesophageal cancer

✍ M.B Polee; J Verweij; P.D Siersema; H.W Tilanus; T.A.W Splinter; G Stoter; A Van 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 103 KB